Integral Health Asset Management, LLC Terns Pharmaceuticals, Inc. Transaction History
Integral Health Asset Management, LLC
- $859 Million
- Q1 2025
A detailed history of Integral Health Asset Management, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 700,000 shares of TERN stock, worth $3.9 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
700,000
Previous 450,000
55.56%
Holding current value
$3.9 Million
Previous $2.51 Million
23.1%
% of portfolio
0.22%
Previous 0.22%
Shares
5 transactions
Others Institutions Holding TERN
# of Institutions
144Shares Held
84.6MCall Options Held
256KPut Options Held
133K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$45.5 Million1.87% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$42.1 Million0.65% of portfolio
-
Morgan Stanley New York, NY7.11MShares$39.6 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$38.4 Million5.17% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$31.1 Million0.54% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $210M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...